Blood Cancer

Blood Cancer or Hematological malignancies are the types of cancer that affect blood, bone marrow, and lymph nodes. As the three are intimately connected through the immune system, a disease affecting one of the three will often affect the others as well.

Blood Cancer - most related articles:

- Blood & ultrasound can diagnose ovarian cancer early - 2.3
- Selenium may worsen prostate cancer in some - 2.3
- New blood test promise diagnosis of colon cancer - 2.2
- Test for targeted therapy in acute myeloid leukemia - 2.2
- Cancer stem cells causing childhood leukemia found - 2.2
- Genes spread breast cancer cells to brain - 2.1
- Researchers identify protein that fuels ovarian cancer - 2
- GenWay Biotech distributor of AMDL's DR-70 cancer test in US and Canada - 2

Blood Cancer articles

PSA test helps predicting biopsy need and low risk prostate cancer
The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released during a meeting of the North Central Section of the American Urological Association in Rancho Mirage, California, US.

New technique extends cancer fighting cells' potency in melanoma patients
Researchers trained white blood cells to attack tumors tend to fade away quickly when injected into cancer patients.

Omega 3 good for heart not for prostate
The largest study ever to examine the association of dietary fats and prostate cancer risk has found what's good for the heart may not be good for the prostate.

Initial trials on new ovarian cancer tests exhibit extremely high accuracy
Scientists at the Georgia Institute of Technology have attained very promising results on their initial investigations of a new test for ovarian cancer. Using a new technique involving mass spectrometry of a single drop of blood serum, the test correctly identified women with ovarian cancer in 100 percent of the patients tested. The results can be found online in the journal Cancer Epidemiology, Biomarkers, & Prevention Research.

Folic acid and vitamin B12 have no beneficial effects in heart disease
A new study revealed that the substantial long-term reductions in blood homocysteine levels with folic acid and vitamin B12 supplementation did not have beneficial effects on vascular outcomes but were also not associated with adverse effects on cancer incidence.

Vitamin B6 lowers risk of lung cancer
An analysis that included nearly 400,000 participants finds that those with higher blood levels of vitamin B6 and the essential amino acid methionine (found in most protein) had an associated lower risk of lung cancer, including participants who were current or former smokers.

Simple blood test may detect ovarian cancer early
Researchers find out that CA-125 protein may help detact ovarian cancer in its early stage. The findings were presented by Karen Lu, M.D., professor in MD Anderson's Department of Gynecologic Oncology, in advance of the American Society of Clinical Oncology (ASCO) annual meeting.

Umbilical cord blood to treat leukemia
Scientists at Fred Hutchinson Cancer Research Center have cleared a major technical hurdle to making umbilical-cord-blood transplants a more widely-used method for treating leukemia and other blood cancers.

New 3 drug combination for multiple myeloma patients
A new three-drug combination has shown in a phase 1/2 clinical trial that it is a "highly effective regimen" in the treatment of patients newly diagnosed with multiple myeloma, a cancer of white blood cells in bone marrow, say researchers from Dana-Farber Cancer Institute.

New blood test promise diagnosis of colon cancer
Promising results from a new blood test that can aid in the early identification of patients with colon cancer will be presented at Europe's largest cancer congress, in Berlin today.

Designing an effective test to detect ovarian cancer
Current diagnostic tests for ovarian cancer are woefully ineffective for early detection of the disease, say researchers at Stanford University School of Medicine.

Thalidomide does not improve survival in lung cancer
Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, revealed by researchers.

Selenium may worsen prostate cancer in some
Higher selenium levels in the blood may worsen prostate cancer in some men who already have the disease, revealed by researchers.

Breast cancer gene responds to blood pressure drug in lab
Researchers have identified a gene that is overexpressed in up to 20 percent of breast cancers and that could be blocked in the lab by a currently available blood pressure drug, according to a new study from the University of Michigan Comprehensive Cancer Center.

Breast cancer markers discovered in breast cancer survivors
A study led by researchers at Fred Hutchinson Cancer Research Center has identified two proteins in the blood that could become important prognostic markers for long-term survival in breast cancer patients.

GenWay Biotech distributor of AMDL's DR-70 cancer test in US and Canada
GenWay Biotech, Inc., a US-based diagnostic company which specializes in providing protein and antibody solutions, announced its partnership with AMDL, Inc., a US-based pharmaceutical company with major operations in China, regarding the distribution of AMDL's DR-70 (FDP) cancer test in both the United States and Canada.

A tiny drop of blood helps to assess cancer details
A drop of blood or a chunk of tissue smaller than the period at the end of this sentence may one day be all that is necessary to diagnose cancers and assess their response to treatment, say researchers at the Stanford University School of Medicine.

Blood & ultrasound can diagnose ovarian cancer early
Blood test combined with ultrasound scan can diagnose ovarian cancer (gynecological cancer) early in postmenopausal women, almost 2 years earlier than normal, reported by the British researchers in the Lancet.

Leukemia treatment developed in Australia
Two Australian research groups are undertaking pioneering studies into the causes of leukaemia, potentially leading to patients receiving new drug treatments as early as next year.

Chemotherapy target found for leukemia
Cancer researchers at the Stanford University School of Medicine have discovered a promising new chemotherapy target for a deadly form of leukemia. Their discovery hinges on a novel "double agent" role for a molecular signal that regulates cell growth.

High GI diets lead to common lifestyle diseases
In the world's first study of its kind, University of Sydney researchers have found conclusive evidence that diets with a high GI (Glycemic Index) leads to a higher risk of common lifestyle diseases.

Researchers identify protein that fuels ovarian cancer
A protein that stimulates blood vessel growth worsens ovarian cancer, but its production can be stifled by a tiny bit of RNA wrapped in a fatty nanoparticle, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the Journal of the National Cancer Institute.

Anemia drugs for cancer patients raises blood clots risk
Treating anemia with a class of drugs known as erythropoiesis-stimulating agents (ESAs) is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs) and death among patients with cancer, according to an article in the February 27 issue of JAMA.

Kids food still full of salt, says CASH
Many foods eaten by UK children still contain large amounts of salt, in some cases more than half the daily maximum limit for a 6 year old in a single serving, revealed by researchers. Research carried out with Netmums, a leading parenting website, also shows that many parents are confused about which foods contain salt.

Genetic testing can gauge prostate cancer risk
Genetic testing of DNA in a blood sample can determine which men are likely to develop prostate cancer, as five genetic variants previously associated with prostate cancer risk have a strong cumulative effect.

Test for targeted therapy in acute myeloid leukemia
An Oregon Health & Science University Cancer Institute researcher has discovered that a particular hormone is responsible for driving a cancer enzyme to cause an often deadly red blood cell cancer.

Understanding chronic myeloid leukemia
Oregon Health & Science University Cancer Institute researchers have opened a new window into the roots of chronic myeloid leukemia (CML). "We are looking under the surface of CML to understand better where the cancer is coming from. We have discovered abnormal cells in the early stem cell population in some CML patients, which don't belong to the CML clone. These are abnormal cells that are not part of the CML clone," said Thomas Bumm, M.D., OHSU Cancer Institute member.

27 Blood Cancer articles listed above.

Subscribe to Health News by Email






What is Blood Cancer
Blood Cancer or Hematological malignancies are the types of cancer that affect blood, bone marrow, and lymph nodes. As the three are intimately connected through the immune system, a disease affecting one of the three will often affect the others as well.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
0.56